| Literature DB >> 33242669 |
Nishaki Kiran Mehta1, Kimberly Doerr2, Andrew Skipper2, Edward Rojas-Pena2, Simon Dixon3, David E Haines3.
Abstract
There are an increasing number of cardiac electronic device implants and generator changes with a longer patient life expectancy along with concomitant increase in antiplatelet and anticoagulant regimens, which can increase the incidence of pocket hematomas. We have conducted an in-depth analysis on the relevant literature, which is rife with varying definition of hematomas, on ways to reduce pocket hematomas. We have analyzed studies on periprocedural medication management, intraprocedural use of prohemostatic agents, and postprocedure role of compression devices.Entities:
Keywords: Anticoagulants; Antiplatelet agents; Cardiac Implantable Electronic Device (CIED) implantation; Hematoma; Pressure dressing; Prohemostatic intraoperative strategies
Mesh:
Year: 2020 PMID: 33242669 DOI: 10.1016/j.hrthm.2020.11.017
Source DB: PubMed Journal: Heart Rhythm ISSN: 1547-5271 Impact factor: 6.343